Cargando…
The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis
BACKGROUND: Ovarian cancer is a malignant tumor with a poor prognosis. Accumulating evidence demonstrates that long non-coding RNAs (lncRNAs) are emerging regulators in cancer biology, and can be used as potential biomarkers for cancer diagnosis, prognosis and targeted therapy. The lncRNA CCAT2 (col...
Autores principales: | Huang, Shuying, Qing, Cheng, Huang, Zikun, Zhu, Yuanfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901397/ https://www.ncbi.nlm.nih.gov/pubmed/27283598 http://dx.doi.org/10.1186/s13000-016-0499-x |
Ejemplares similares
-
Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells
por: Guo, Hua, et al.
Publicado: (2016) -
Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2
por: Wang, Liye, et al.
Publicado: (2020) -
Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019) -
CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai, Yi, et al.
Publicado: (2018) -
Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial–mesenchymal transition
por: Xu, Yongfu, et al.
Publicado: (2017)